Proleukin [aldesleukin] in combination with Rituxan [rituximab] in patients with low-grade non-Hodgkin's lymphoma who have previously failed Rituxan treatments
Phase of Trial: Phase II/III
Latest Information Update: 03 Feb 2006
At a glance
- Drugs Aldesleukin; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Sep 2005 New trial record.